title: Pediatric intestinal transplantation at Packard Children's Hospital/Stanford University Medical Center: report of a four-year experience.
abstract: We report a 4-year experience of a new program in pediatric intestinal transplantation. Among 50 children referred for evaluation, 27 were listed for transplantation. Two children originally listed for combined liver/small bowel transplant were changed to isolated intestinal transplant as rehabilitation efforts resulted in full recovery of hepatic function. Eighteen children received 18 grafts: 12 liver/intestine, 5 isolated intestine, and 1 multivisceral. Mean age at transplant was 3.6 year with 75% of patients aged 0 to 2 years. Five listed children died while waiting and four were still on the list. Immunotherapy included antithymocyte globulin induction and tacrolimus, sirolimus, and prednisone maintenance. At 1 year, patient and graft survivals were 75% and 67%, respectively. For isolated intestine, 1 year survivals were 100% and 75%, while for combined liver/intestine, they were 71% for both. Enteral autonomy is 100% with total parenteral nutrition stopping by 35.8 days (mean). We had two patients develop posttransplant lymphoproliferative disorder and three, exfoliative rejection, one of whom recovered completely. In conclusion, our program in pediatric intestinal transplantation has become well established with a high proportion of smaller/younger children receiving grafts. Outcomes achieved levels expected based on The Intestinal Transplant Registry and UNOS criteria, which were better than expected for isolated intestinal transplants and achievement of enteral autonomy.
authors.affiliation: Division of Gastroenterology, Nutrition and Liver Disease, Department of Pediatrics, Packard Children's Hospital, Palo Alto, CA 94304, USA. ricardo.castillo@stanford.edu
authors.forename: R O
authors.initials: RO
authors.lastname: Castillo
authors.forename: R
authors.initials: R
authors.lastname: Zarge
authors.forename: K
authors.initials: K
authors.lastname: Cox
authors.forename: D
authors.initials: D
authors.lastname: Strichartz
authors.forename: W
authors.initials: W
authors.lastname: Berquist
authors.forename: C A
authors.initials: CA
authors.lastname: Bonham
authors.forename: C O
authors.initials: CO
authors.lastname: Esquivel
mesh_terms: D000017:ABO Blood-Group System; D001787:Blood Group Incompatibility; D002140:California; D002648:Child; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007422:Intestines / Q000637:transplantation*; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology / Q000379:methods* / Q000401:mortality
chemical_list: D000017:ABO Blood-Group System